@jimbrown10321 $MYRX is not doomed. The CEO is a sharp investor. The company is now a holding company that owns various life sciences assets and is worth a lot more than the current share price. The company is saving money by not reporting to the SEC.
I think this will change as the company continues to acquire more assets. It will need to be fully reporting if it wants to access the capital markets.
$MYRX [15s. delayed] filed SEC form 4: 10% Owner COUCHMAN JONATHAN:
Disposed 107,500 of Common Stock at average price $0.39 on 2021-08-13 https://s.flashalert.me/8dWRb7
@macroaxis Couchman owns both $AFFY and $MYRX. You should look at $MYRX. It’s .04 and would have to run up to .40+ to have same market cap as AFFY. MYRX also has been buying shares of ENZN
$MYRX [15s. delayed] filed SEC form 4: 10% Owner COUCHMAN JONATHAN:
Acquired 506,292 of Common Stock at price $0.2 on 2020-08-05, increas https://s.flashalert.me/bYPtUn
$MYRX - MYREXIS INC has high likelihood to experience… https://www.macroaxis.com/invest/market/MYRX--diagnostics--MYREXIS-INC #insidertrading #stocks #fintechnews
